Tickers: XCNQ:MMJ, PINX:MPQXF
Tags: Medicinal Marijuana
Toronto, Ontario / TheNewswire / March 3, 2017 - Matica Enterprises Inc. (MMJ-CSE) (39N - Frankfurt) (MQPXF - OTC PINK) ("Matica" or the "Company") at the request of the Investment Industry Regulatory Organization of Canada, confirms that its management is unaware of any material change to the company or its business that would account for the recent increase in market activity.
Management is however pleased to report that further to our November 17, 2016 News Release the Company has been reviewing the facilities of several late stage applicants under the Access To Cannabis for Medical Purposes Regulation ("ACMPR"). We are currently in negotiations, but have not formalized any arrangement at this time.
For more information on Matica please visit the website at: www.maticaenterprises.com.
On behalf of the Board of Directors
MATICA ENTERPRISES INC.
/s/Boris Ziger
Boris Ziger, CEO & Chairman
The Company's filings are available for review at www.sedar.com and www.thecse.com.
For further information, please contact Boris Ziger, Chief Executive Officer, at:
Telephone: 416-304-9935
E-mail: info@maticaenterprises.com
Website: www.maticaenterprises.com
Certain information in this press release may constitute forward-looking information. This information is based on current expectations that are subject to significant risks and uncertainties that are difficult to predict. Actual results might differ materially from results suggested in any forward-looking statements. The Corporation assumes no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those reflected in the forward looking-statements unless and until required by securities laws applicable to the Corporation. Additional information identifying risks and uncertainties is contained in the Corporation's filings with the Canadian securities regulators, which filings are available at www.sedar.com.
The CSE has not reviewed, approved or disapproved the content of this press release.
Copyright (c) 2017 TheNewswire - All rights reserved.
